Liquidia Corporation (LQDA) Financials

LQDA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 401.5 million 293.0 million
Dec. 31, 2025 327.9 million 283.2 million
Sept. 30, 2025 276.0 million 253.9 million
June 30, 2025 257.4 million 242.2 million

LQDA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 50.2 million 9.2 million
Dec. 31, 2025 42.2 million 7.2 million
Sept. 30, 2025 -10.7 million 7.9 million
June 30, 2025 -40.5 million 6.9 million

LQDA Net Income

No data available :(

LQDA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 222.8 million 127.6 million 6.2 million
Dec. 31, 2025 190.7 million 132.9 million 6.1 million
Sept. 30, 2025 157.5 million 136.4 million 6.7 million
June 30, 2025 173.4 million 149.5 million 6.8 million

LQDA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 101.1 million
Dec. 31, 2025 100.1 million
Sept. 30, 2025 86.3 million
June 30, 2025 85.6 million

LQDA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2.8 million 12.3 million 46.9 million -
Dec. 31, 2025 2.0 million 16.9 million 48.2 million -
Sept. 30, 2025 911000 9.3 million 40.1 million -
June 30, 2025 1.1 million 6.0 million 38.8 million -

LQDA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 132.9 million 12.1 million
Dec. 31, 2025 92.0 million 7.1 million
Sept. 30, 2025 54.3 million 3.2 million
June 30, 2025 8.8 million 1.3 million

LQDA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

LQDA

Price: $71.40

52 week price:
11.85
71.63

Earnings Per Share: 0.17 USD

P/E Ratio: 334.88

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 65756

Market Capitalization: 5.5 billion

Links: